Indian Companies Expand Globally: Pharma, Rare Earths, Rail
By ThePip Desk
Indian companies Marksans Pharma, Midwest, and Jayant Infratech are expanding internationally in pharma, rare earths, and rail infrastructure, showcasing global growth.
🔥 Indian companies are making strategic moves both globally and domestically, with Marksans Pharma expanding into Germany, Midwest exploring rare earths in Indonesia, and Jayant Infratech securing a significant railway electrification contract.
📌 What Happened?
Marksans Pharma finalized an agreement to acquire 100% of ABCnow GmbH, a German pharmaceutical company, for 892,384 euro; the deal is set to close by July 31, 2026.
This acquisition provides Marksans with direct sales, marketing, and distribution channels in the German healthcare market for its products manufactured in India, UK, and USA regions.
Midwest, along with Midwest Energy and NFTDC, signed a Memorandum of Understanding with Indonesia’s state-owned PT Perusahaan Mineral Nasional (PERMINAS) for rare earth collaboration.
The MoU covers the entire rare earth value chain in Indonesia, from upstream exploration and mining to processing, refining, and downstream manufacturing like rare earth magnet production.
Jayant Infratech secured a Letter of Acceptance from West Central Railway for a Rs 13.31 crore contract to execute railway overhead electrification works in the Itarsi-Jhujharpur section by April 9, 2027.
💰 Why It Matters
Marksans’ strategic acquisition in Germany directly expands its global footprint and market access, potentially boosting international revenue streams and brand presence in a key European economy.
Midwest’s rare earth deal positions it in a critical minerals sector vital for future technology and green energy, signaling India’s push for resource security and diversified global supply chains.
Jayant Infratech’s railway contract highlights continued government investment in modernizing India’s railway infrastructure, offering stable growth opportunities for domestic engineering and construction firms.
These strategic actions indicate a broader trend of Indian companies actively pursuing both international growth and capitalizing on robust domestic development projects.
👀 What to Watch Next
Monitor Marksans Pharma’s integration of ABCnow GmbH and its sales performance in the German market post-acquisition completion in 2026.
Look for further announcements from Midwest regarding specific projects or investments emerging from the rare earth MoU with PERMINAS in Indonesia.
Track Jayant Infratech’s execution of the railway electrification project and potential for securing additional large-scale infrastructure contracts as India expands its rail network.